The Business Times20h
AstraZeneca seeks to move past China probe with Beijing R&D hub
HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
Foreign CEOs, including Tim Cook of Apple, as well as Republican Sen. Steve Daines are in Beijing for the two-day China ...
BioSpace1d
AstraZeneca Makes Potential $10B+ China Commitment Despite Political Pressure
The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...
China Daily Global Edition1d
AstraZeneca puts faith in innovation
Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...
Medical Dialogues1d
AstraZeneca to inject USD 2.5 billion in new RnD centre, biotech pacts, manufacturing in Beijing
Beijing: AstraZeneca has announced an investment of USD 2.5 billion in Beijing to establish its sixth global strategic R&D ...
Harbour BioMed Shares Soar on News of AstraZeneca Collaboration
AstraZeneca's five-year US$2.5 billion investment, announced on Friday, includes a new research-and-development center in Beijing and a research agreement with Harbour BioMed. The U.K. firm will also ...